n,n-dimethylarginine has been researched along with Psoriasis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Altınyazar, HC; Baran, H; Bilgiç, Ö; Ünlü, A | 1 |
| Armesto, S; Blanco, R; Corrales, A; Dierssen-Sotos, T; Genre, F; Gonzalez-Gay, MA; Gonzalez-Lopez, MA; Gonzalez-Vela, MC; Hernández, JL; Llorca, J; Lopez-Mejias, R; Mijares, V; Pina, T; Ubilla, B | 1 |
| Aral, H; Gurel, MS; Guvenen, G; Inal, BB; Oner, E; Oner, FA; Turan, E; Usta, M; Yurdakul, S | 1 |
3 other study(ies) available for n,n-dimethylarginine and Psoriasis
| Article | Year |
|---|---|
Serum homocysteine, asymmetric dimethyl arginine (ADMA) and other arginine-NO pathway metabolite levels in patients with psoriasis.
Topics: Adult; Arginine; Biomarkers; Enzyme Inhibitors; Female; Homocysteine; Humans; Male; Middle Aged; Nitric Oxide; Psoriasis; Signal Transduction; Young Adult | 2015 |
Asymmetric dimethylarginine but not osteoprotegerin correlates with disease severity in patients with moderate-to-severe psoriasis undergoing anti-tumor necrosis factor-α therapy.
Topics: Adalimumab; Adult; Anti-Inflammatory Agents; Arginine; Biological Therapy; Biomarkers; Female; Humans; Male; Middle Aged; Osteoprotegerin; Prospective Studies; Psoriasis; Resistin; Tumor Necrosis Factor-alpha | 2016 |
Vascular endothelial function assessed by a noninvasive ultrasound method and serum asymmetric dimethylarginine concentrations in mild-to-moderate plaque-type psoriatic patients.
Topics: Acute-Phase Proteins; Adult; Arginine; C-Reactive Protein; Case-Control Studies; Endothelium, Vascular; Female; Fibrinogen; Humans; Male; Psoriasis; Severity of Illness Index; Ultrasonography; Vasodilation | 2011 |